Premium
The role of positron emission tomography in the evaluation of inflammatory bowel disease
Author(s) -
Chandler Matthew B.,
Zeddun Steven M.,
Borum Marie L.
Publication year - 2011
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2011.06032.x
Subject(s) - inflammatory bowel disease , positron emission tomography , medicine , disease , endoscopy , inflammatory bowel diseases , gastrointestinal tract , radiology
Inflammatory bowel disease (IBD) is a chronic inflammatory disease that affects the gastrointestinal tract. Information obtained from a clinical history, physical exam, laboratory testing, imaging studies, and endoscopic evaluations must be combined to accurately diagnose IBD. Further testing often becomes necessary to evaluate symptom relapse in patients with an established IBD diagnosis. Endoscopy, while effective in assessing mucosal disease, is invasive and associated with inherent risks. Positron emission tomography (PET) is an effective, noninvasive tool for the evaluation of active inflammation. This review will focus on the role of PET imaging in the evaluation and management of IBD.